Low-dose Aspirin Does Not Appear To Reduce Risk Of CV Events In Patients With Diabetes

Low-dose aspirin as primary prevention did not appear to significantly reduce the risk of a combined end point of coronary, cerebrovascular and peripheral vascular events in patients with type-2 diabetes, according to a new study. However, aspirin did significantly reduce the combination of fatal coronary and fatal cerebrovascular events.

Read the whole article on Science Daily

More from Science Daily